| Literature DB >> 30625314 |
Annabelle Suisse1, Jessica E Treisman2.
Abstract
Calcium homeostasis in the lumen of the endoplasmic reticulum is required for correct processing and trafficking of transmembrane proteins, and defects in protein trafficking can impinge on cell signaling pathways. We show here that mutations in the endoplasmic reticulum calcium pump SERCA disrupt Wingless signaling by sequestering Armadillo/β-catenin away from the signaling pool. Armadillo remains bound to E-cadherin, which is retained in the endoplasmic reticulum when calcium levels there are reduced. Using hypomorphic and null SERCA alleles in combination with the loss of the plasma membrane calcium channel Orai allowed us to define three distinct thresholds of endoplasmic reticulum calcium. Wingless signaling is sensitive to even a small reduction, while Notch and Hippo signaling are disrupted at intermediate levels, and elimination of SERCA function results in apoptosis. These differential and opposing effects on three oncogenic signaling pathways may complicate the use of SERCA inhibitors as cancer therapeutics.Entities:
Keywords: Drosophila; E-cadherin; Hippo; Notch; SERCA; Wnt; calcium; endoplasmic reticulum; wing disc; β-catenin
Mesh:
Substances:
Year: 2019 PMID: 30625314 PMCID: PMC6338334 DOI: 10.1016/j.celrep.2018.12.049
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423
Figure 1.SERCA Mutations Affect Wg Signaling
(A) Diagram of the SERCA gene, showing the coding region in blue and the positions of the introns. Below is the encoded protein, showing the transmembrane domains (gray), actuator domain (red), phosphorylation domain (blue), and nucleotide-binding domain (green). Asterisks indicate the positions of the dsm, S5, and Kum170 mutations.
(B-G) Third instar wing imaginal discs containing SERCA (B), SERCA (C and G), arr (D), arr, SERCA (E), or cul1 (F) clones marked by the absence of RFP (green). Anterior is to the left and dorsal up in this and all subsequent figures. Discs are stained with anti-Al (B’-E’, red in B-E), anti-Arm (B”-E”, F’, and G’; blue in B-E, red in F and G), or anti-phospho-Arm (F” and G”; blue in F and G). Al levels decrease and unphosphorylated Arm accumulates in SERCA mutant clones. Arm also accumulates in arr, SERCA double mutant clones, but not in arr clones. Scale bar, 50 μm. n ≥ 10 discs for all stainings shown in this and all subsequent figures.
See also Figure S1.
Figure 2.E-Cad Is Retained in the Endoplasmic Reticulum and Traps Arm There in the Absence of SERCA
(Aand B) Wing disc containing SERCA clones marked bythe absence of RFP (green) stained with anti-Arm (A’ and A”’; red in A) and anti-E-Cad (A” and A””; blue in A). Subapical sections are shown in A-A”, and apical sections in A”’ and A””. Scale bar, 50 μm.
(B) z projection through the disc at the position shown by the line in (A), with apical up. In mutant cells, E-Cad colocalizes with Arm below the AJs.
(C-F) S2 cells co-transfected with Act-GAL4 and UAS-E-Cad and treated with DMSO (C and D)or10 μM thapsigargin (Tg) (E and F) were stained with anti-E-Cad (C’-F’; green in C-F), phalloidin (C” and E”; red in C-F), anti-Cnx99A (C”’ and E”’; blue in C and E), or anti-Arm (D” and F”; blue in D and F). Scale bar, 5 μM. (G) Quantification of the percentage of cells (means ± SEMs) in which E-Cad is localized at the plasma membrane in Tg- or DMSO-treated cells. ****p < 0.0001 by unpaired t test on three independent experiments. InTg-treated cells, E-Cad does not reach the plasma membrane and colocalizes with Cnx99A. Arm colocalizes with E-Cad in control and Tg-treated cells.
(H-K) Wing discs with wild-type (H) or SERCA clones (I) expressing E-Cad RNAi, E-Gad clones (J) or SERCA, E-Gad clones (K). Clones are positively marked with GFP (green) and stained with anti-Al (H’-K’; red in H-K) and anti-Arm (H”-K”; blue in H-K). E-Cad rescuesArm accumulation and al expression in SERCA clones.
See also Figure S2.
Figure 3.Three Levels of ER Stress Induced by SERCA and orai Mutations
(A-F) Wing discs with orai (A), SERCA, orai (B), SERCA, orat (Cand E), SERCA (D), or SERCA (F)clones labeled bytheabsence ofRFP (green).
(A-C) Discs are stained with anti-Al (A’-C’; red in A-C) and anti-Arm (A”-C”; blue in A-C). Scale bar, 50 μm. Disrupting Orai channel function does not rescue SERCA mutants.
(D-F) The endoplasmic reticulum (ER) stress reporter Xbp-1-GFP (D’-F’; red in D-F) is driven in the posterior compartment with hh-Gal4. Discs are also stained with anti-activated caspase 3 (basal sections shown in D”-F”; blue in D-F). Loss of orai increases ER stress in SERCA cells, but not to the level seen in SERCA cells, which induces apoptosis.
(G) Quantification ofXbp1-GFP intensity in SERCA; SERCA, orai; and SERCA clones. Box-and-whisker plot shows median bounded by minimum, first quartile, third quartile, and maximum. SERCA, n = 22 clones in 5 wing discs; SERCA, orai n = 22 clones in 6 discs; SERCA n = 29 clones in 7 discs; ****p < 0.0001 by Welch’s ANOVA.
See also Figure S3.
Figure 4.Hippo and Notch Signaling Pathways Are Affected by Moderate ER Stress
(A-L) Wing imaginal discs with SERCA (A, D, G, and J), SERCA, orai (B, E, H, and K), or SERCA clones (C, F, I, and L), marked by the absence of RFP (green) and stained with antibodies to Fat (A’-C’; magenta in A-C), Dachs (D’-F’; magenta in D-F), Notch (G’-I’; magenta in G-I), or Cut (J’-L’; magenta in J-L). Scale bar, 50 mm. Subapical sections are shown, except in (D)-(F), which show the apical membrane. Although there is a weak subapical accumulation of Fat and Notch in SERCA clones, Dachs and Cut are not affected. Decreasing levels of ER Ca2+ in SERCA, orai and SERCA clones cause an increasing accumulation of Fat and Notch, leading to the membrane localization of Dachs and loss of Cut.
See also Figure S4.
KEY RESOURCES TABLE
| REAGENT or RESOURCE | SOURCE | IDENTIFIER |
|---|---|---|
| Antibodies | ||
| Rat polyclonal anti-Aristaless | N/A | |
| Chicken polyclonal anti-GFP | Invitrogen | Cat# A10262 |
| Mouse monoclonal anti-Armadillo | Developmental Studies Hybridoma Bank | Cat # N2 7A1; RRID AB_528089 |
| Rabbit polyclonal anti-phospho-β-catenin (Ser45) | Cell Signaling | Cat # 9564; RRID AB_331150 |
| Rat monoclonal anti-E-cadherin | Developmental Studies Hybridoma Bank | Cat # DCAD2; RRID AB_528120 |
| Rabbit polyclonal anti-active caspase 3 | BD PharMingen | Cat # 559565 |
| Mouse monoclonal anti-Notch | Developmental Studies Hybridoma Bank | Cat # C17.9C6; RRID AB_528410 |
| Mouse monoclonal anti-Cut | Developmental Studies Hybridoma Bank | Cat # 2B10; RRID AB_528186 |
| Mouse monoclonal anti-Cnx99A | Developmental Studies Hybridoma Bank | Cat # Cnx99A 6-2-1; RRID AB_2722011 |
| Mouse monoclonal anti-Achaete | Developmental Studies Hybridoma Bank | Cat # anti-achaete; RRID AB_528066 |
| Mouse monoclonal anti-Frizzled2 | Developmental Studies Hybridoma Bank | Cat # 1A3G4; RRID AB_528257 |
| Mouse monoclonal anti-Crumbs | Developmental Studies Hybridoma Bank | Cat # Cq4; RRID AB_528181 |
| Rabbit polyclonal anti-Fat | N/A | |
| Rabbit polyclonal anti-Dachs | N/A | |
| Rat polyclonal anti-Distal-less | N/A | |
| Rabbit polyclonal anti-Vestigial | N/A | |
| Guinea pig polyclonal anti-Senseless | N/A | |
| Rabbit polyclonal anti-Epidermal Growth Factor Receptor | N/A | |
| Rabbit polyclonal anti-Hibris | N/A | |
| Alexa Fluor 555-conjugated phalloidin | Invitrogen | Cat # A34055 |
| Chemicals, Peptides, and Recombinant Proteins | ||
| Effectene Transfection Reagent | QIAGEN | Cat # 301425 |
| Tg | Santa Cruz Biotechnology | Cat # sc-24017 |
| GIBCO® Schneider’s | Invitrogen | Cat #21720001 |
| GIBCO® Fetal bovine serum, qualified, heat inactivated | Invitrogen | Cat# 16140–071 |
| Experimental Models: Cell Lines | ||
| Laboratory of Ruth Lehmann | FlyBase: FBtc0000181 | |
| Experimental Models: Organisms/Strains | ||
| This paper | N/A | |
| Flybase: FBal0184441 | ||
| Flybase: FBal0101766 | ||
| Bloomington | BDSC:11042; Flybase: FBst0011042 | |
| Flybase: FBal0155633 | ||
| Flybase: FBtp0071231 | ||
| N/A | ||
| N/A | ||
| Flybase: FBal0230351 | ||
| Bloomington | BDSC:32904; Flybase: FBst0032904 | |
| Bloomington | BDSC:41758; Flybase: FBst0041758 | |
| Flybase: FBal0141058 | ||
| Flybase: FBal0121005 | ||
| Bloomington | FlyBase: FBti0150334 | |
| Bloomington | FlyBase: FBti0017278 | |
| Bloomington | FlyBase: FBab0045520 | |
| Bloomington | FlyBase: FBab0045836 | |
| Recombinant DNA | ||
| pActin-GAL4 plasmid | Laboratory of Nathalie Dostatni | Flybase: FBal0097155 |
| pUAS-Ecad plasmid | N/A | |
| Software and Algorithms | ||
| ImageJ 1.50d | National Institutes of Health | |
| GraphPad Prism 7.0c | GraphPad Software, Inc. |